Other Viruses Citation List: September 27 - October 24, 2013

Hepatitis A Virus

1. Comparison of the Virucidal Efficiency of Peracetic acid, Potassium monopersulfate and Sodium hypochlorite on Hepatitis A and Enteric Cytopathogenic Bovine Orphan Virus. Martin, H., C. Soumet, R. Fresnel, T. Morin, S. Lamaudiere, A.L. Le Sauvage, K. Deleurme, and P. Maris. Journal of Applied Microbiology, 2013. 115(4): p. 955-968; PMID[23906424].

[PubMed] OV_1011-102413.

Hepatitis B Virus

2. Biological Activity of Oleanane Triterpene Derivatives Obtained by Chemical Derivatization. Cheng, S.Y., C.M. Wang, H.L. Cheng, H.J. Chen, Y.M. Hsu, Y.C. Lin, and C.H. Chou. Molecules, 2013. 18(10): p. 13003-13019; PMID[24145793].

[PubMed] OV_1011-102413.

3. 5'-Triphosphate-siRNA Activates RIG-I-dependent Type I Interferon Production and Enhances Inhibition of Hepatitis B Virus Replication in HepG2.2.15 Cells. Chen, X., Y. Qian, F. Yan, J. Tu, X. Yang, Y. Xing, and Z. Chen. European Journal of Pharmacology, 2013. [Epub ahead of print]; PMID[24099962].

[PubMed] OV_1011-102413.

4. Specific Inhibition of Hepatitis C Virus Entry into Host Hepatocytes by Fungi-derived Sulochrin and Its Derivatives. Nakajima, S., K. Watashi, S. Kamisuki, S. Tsukuda, K. Takemoto, M. Matsuda, R. Suzuki, H. Aizaki, F. Sugawara, and T. Wakita. Biochemical and Biophysical Research Communications, 2013. [Epub ahead of print]; PMID[24099774].

[PubMed] OV_1011-102413.

5. Inhibition of Hepatitis B Virus Replication in Cultured Cells and in Vivo Using 2'-O-Guanidinopropyl Modified SiRNAs. Marimani, M.D., A. Ely, M.C. Buff, S. Bernhardt, J.W. Engels, and P. Arbuthnot. Bioorganic & Medicinal Chemistry, 2013. 21(20): p. 6145-6155; PMID[23743442].

[PubMed] OV_1011-102413.

Hepatitis C Virus

6. Discovery and Early Development of TMC647055, a Non-nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. Cummings, M.D., T.I. Lin, L. Hu, A. Tahri, D. McGowan, K. Amssoms, S. Last, B. Devogelaere, M.C. Rouan, L. Vijgen, J.M. Berke, P. Dehertogh, E. Fransen, E. Cleiren, L. van der Helm, G. Fanning, O. Nyanguile, K. Simmen, P. Van Remoortere, P. Raboisson, and S. Vendeville. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24144360].

[PubMed] OV_1011-102413.

7. The Discovery of GS-9669, a Thumb Site II Non-nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection. Lazerwith, S.E., W. Lew, J. Zhang, P. Morganelli, Q. Liu, E. Canales, M.O. Clarke, E. Doerffler, D. Byun, M. Mertzman, H. Ye, L. Chong, L. Xu, T. Appleby, X. Chen, M. Fenaux, A. Hashash, S. Leavitt, E. Maybery, M. Matles, J.W. Mwangi, Y. Tian, Y.J. Lee, J. Zhang, C. Zhu, B.P. Murray, and W.J. Watkins. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24144213].

[PubMed] OV_1011-102413.

8. Hepatitis C Virus Translation Inhibitors Targeting the Internal Ribosomal Entry Site. Dibrov, S.M., J. Parsons, M. Carnevali, S. Zhou, K.D. Rynearson, K. Ding, E. Garcia Sega, N.D. Brunn, M.A. Boerneke, M.P. Castaldi, and T. Hermann. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24138284].

[PubMed] OV_1011-102413.

9. Azetidines and Spiro Azetidines as Novel P2 Units in Hepatitis C Virus NS3 Protease Inhibitors. Bondada, L., R. Rondla, U. Pradere, P. Liu, C. Li, D. Bobeck, T. McBrayer, P. Tharnish, J. Courcambeck, P. Halfon, T. Whitaker, F. Amblard, S.J. Coats, and R.F. Schinazi. Bioorganic & Medicinal Chemistry Letters, 2013. [Epub ahead of print]; PMID[24135727].

[PubMed] OV_1011-102413.

10. The Versatile Nature of the 6-Aminoquinolone Scaffold: Identification of Submicromolar Hepatitis C Virus NS5B Inhibitors. Manfroni, G., R. Cannalire, M.L. Barreca, N. Kaushik-Basu, P. Leyssen, J. Winquist, N. Iraci, D. Manvar, J. Paeshuyse, R. Guhamazumder, A. Basu, S. Sabatini, O. Tabarrini, U.H. Danielson, J. Neyts, and V. Cecchetti. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24131104].

[PubMed] OV_1011-102413.

11. High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A Proteases from Multiple Hepatitis C Virus Genotypes. Lee, H., T. Zhu, K. Patel, Y.Y. Zhang, L. Truong, K.E. Hevener, J.L. Gatuz, G. Subramanya, H.Y. Jeong, S.L. Uprichard, and M.E. Johnson. Plos One, 2013. 8(10): p. e75144; PMID[24130685].

[PubMed] OV_1011-102413.

12. Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity. Coburn, C.A., P.T. Meinke, W. Chang, C.M. Fandozzi, D.J. Graham, B. Hu, Q. Huang, S. Kargman, J. Kozlowski, R. Liu, J.A. McCauley, A.A. Nomeir, R.M. Soll, J.P. Vacca, D. Wang, H. Wu, B. Zhong, D.B. Olsen, and S.W. Ludmerer. ChemMedChem, 2013. [Epub ahead of print]; PMID[24127258].

[PubMed] OV_1011-102413.

13. Preclinical Characterization of GSK2336805, a Novel Inhibitor of Hepatitis C Virus Replication That Selects for Resistance in NS5A. Walker, J., R. Crosby, A. Wang, E. Woldu, J. Vamathevan, C. Voitenleitner, S. You, K. Remlinger, M. Duan, W. Kazmierski, and R. Hamatake. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[24126581].

[PubMed] OV_1011-102413.

14. Curcumin against Hepatitis C Virus Infection: Spicing up Antiviral Therapies with 'Nutraceuticals'? Pecheur, E.I. Gut, 2013. [Epub ahead of print]; PMID[24092864].

[PubMed] OV_1011-102413.

15. Use of 2'-Spirocyclic Ethers in HCV Nucleoside Design. Du, J., B.K. Chun, R.T. Mosley, S. Bansal, H. Bao, C. Espiritu, A.M. Lam, E. Murakami, C. Niu, H.M. Micolochick Steuer, P.A. Furman, and M.J. Sofia. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24079820].

[PubMed] OV_1011-102413.

16. Discovery of a Novel Series of Potent Non-nucleoside Inhibitors of Hepatitis C Virus NS5B. Schoenfeld, R.C., D.L. Bourdet, K.A. Brameld, E. Chin, J. de Vicente, A. Fung, S.F. Harris, E.K. Lee, S. Le Pogam, V. Leveque, J. Li, A.S. Lui, I. Najera, S. Rajyaguru, M. Sangi, S. Steiner, F.X. Talamas, J.P. Taygerly, and J. Zhao. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24069953].

[PubMed] OV_1011-102413.

17. Enantiomeric Atropisomers Inhibit HCV Polymerase and/or HIV Matrix: Characterizing Hindered Bond Rotations and Target Selectivity. Laplante, S.R., P. Forgione, C. Boucher, R. Coulombe, J. Gillard, O. Hucke, A. Jakalian, M.A. Joly, G. Kukolj, C. Lemke, R. McCollum, S. Titolo, P.L. Beaulieu, and T. Stammers. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[24024973].

[PubMed] OV_1011-102413.

18. A Fluorescence-based High-Throughput Screen to Identify Small Compound Inhibitors of the Genotype 3a Hepatitis C Virus RNA Polymerase. Eltahla, A.A., K. Lackovic, C. Marquis, J.S. Eden, and P.A. White. Journal of Biomolecular Screening, 2013. 18(9): p. 1027-1034; PMID[23708123].

[PubMed] OV_1011-102413.

19. Screening for Inhibitors of the Hepatitis C Virus Internal Ribosome Entry Site RNA. Zhou, S., K.D. Rynearson, K. Ding, N.D. Brunn, and T. Hermann. Bioorganic & Medicinal Chemistry, 2013. 21(20): p. 6139-44; PMID[23602522].

[PubMed] OV_1011-102413.

Human Cytomegalovirus

20. Synthesis of Some New Benzisothiazolone and Benzenesulfonamide Derivatives of Biological Interest Starting from Saccharin sodium. El-Sabbagh, O.I. Archiv der Pharmazie, 2013. 346(10): p. 733-742; PMID[24038507].

[PubMed] OV_1011-102413.

21. Modulation of the Cellular Distribution of Human Cytomegalovirus Helicase by Cellular Factor Snapin. Luo, J., J. Chen, E. Yang, A. Shen, H. Gong, Z. Pei, G. Xiao, S. Lu, and F. Liu. Journal of Virology, 2013. 87(19): p. 10628-10640; PMID[23885069].

[PubMed] OV_1011-102413.

Herpes Simplex Virus 1

22. Antibacterial and Antiviral Evaluation of Sulfonoquinovosyldiacylglyceride (SQDG): A Glycolipid Isolated from Azadirachta indica Leaves. Bharitkar, Y.P., S. Bathini, D. Ojha, S. Ghosh, H. Mukherjee, K. Kuotsu, D. Chattopadhyay, and N.B. Mondal. Letters in Applied Microbiology, 2013. [Epub ahead of print]; PMID[24118020].

[PubMed] OV_1011-102413.

23. The Antiviral Activities of ISG15. Morales, D.J. and D.J. Lenschow. Journal of Molecular Biology, 2013. [Epub ahead of print]; PMID[24095857].

[PubMed] OV_1011-102413.

24. Sulfonyl-polyol N,N-dichloroamines with Rapid, Broad-spectrum Antimicrobial Activity. Shiau, T.P., E. Low, B. Kim, E.D. Turtle, C. Francavilla, D.J. O'Mahony, L. Friedman, L. D'Lima, A. Jekle, D. Debabov, M. Zuck, N.J. Alvarez, M. Anderson, R.R. Najafi, and R.K. Jain. Bioorganic & Medicinal Chemistry Letters, 2013. 23(20): p. 5650-5653; PMID[23999044].

[PubMed] OV_1011-102413.

Herpes Simplex Virus 2

25. In Vitro anti-Herpes Simplex Virus Activity of Crude Extract of the Roots of Nauclea latifolia Smith (Rubiaceae). Donalisio, M., H.M. Nana, R.A. Ngono Ngane, D. Gatsing, A. Tiabou Tchinda, R. Rovito, V. Cagno, C. Cagliero, F.F. Boyom, P. Rubiolo, C. Bicchi, and D. Lembo. BMC Complementary and Alternative Medicine, 2013. 13(1): p. 266; PMID[24131916].

[PubMed] OV_1011-102413.

26. Analysis of Compounds That Interfere with Herpes Simplex Virus-host Receptor Interactions Using Surface Plasmon Resonance. Gopinath, S.C., K. Hayashi, J.B. Lee, A. Kamori, C.X. Dong, T. Hayashi, and P.K. Kumar. Analytical Chemistry, 2013. [Epub ahead of print]; PMID[24079703].

[PubMed] OV_1011-102413.

Kaposi

27. O-GlcNAc Transferase Inhibits Kshv Propagation and Modifies Replication Relevant Viral Proteins as Detected by Systematic O-GlcNAcylation Analysis. Jochmann, R., J. Pfannstiel, P. Chudasama, E. Kuhn, A. Konrad, and M. Sturzl. Glycobiology, 2013. 23(10): p. 1114-1130; PMID[23580777].

[PubMed] OV_1011-102413.

Citations from the ISI Web of Knowledge Listings for O.V.

28. Design, Synthesis, and Biological Evaluation of New 2 '-Deoxy-2 '-fluoro-4 '-triazole Cytidine Nucleosides as Potent Antiviral Agents. Wu, J., W.Q. Yu, L.X. Fu, W. He, Y. Wang, B.S. Chai, C.J. Song, and J.B. Chang. European Journal of Medicinal Chemistry, 2013. 63: p. 739-745; ISI[000322855400073].

[WOS] OV_1011-102413.

29. Perovskatone A: A Novel C-23 Terpenoid from Perovskia Atriplicifolia. Jiang, Z.Y., C.G. Huang, H.B. Xiong, K. Tian, W.X. Liu, Q.F. Hu, H.B. Wang, G.Y. Yang, and X.Z. Huang. Tetrahedron Letters, 2013. 54(29): p. 3886-3888; ISI[000324005200041].

[WOS] OV_1011-102413.

30. A Serine Palmitoyltransferase Inhibitor Blocks Hepatitis C Virus Replication in Human Hepatocytes. Katsume, A., Y. Tokunaga, Y. Hirata, T. Munakata, M. Saito, H. Hayashi, K. Okamoto, Y. Ohmori, I. Kusanagi, S. Fujiwara, T. Tsukuda, Y. Aoki, K. Klumpp, K. Tsukiyama-Kohara, A. El-Gohary, M. Sudoh, and M. Kohara. Gastroenterology, 2013. 145(4): p. 865-873; ISI[000324474600032].

[WOS] OV_1011-102413.

31. Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation. Panigrahi, R., S. Hazari, S. Chandra, P.K. Chandra, S. Datta, R. Kurt, C.E. Cameron, Z.H. Huang, H.T. Zhang, R.F. Garry, L.A. Balart, and S. Dash. Plos One, 2013. 8(8): p. e72791; ISI[000324403200032].

[WOS] OV_1011-102413.

32. Inhibition of HCV Replication by Oxysterol-binding Protein-related Protein 4 (Orp4) through Interaction with HCV NS5B and Alteration of Lipid Droplet Formation. Park, I.W., J. Ndjomou, Y.H. Wen, Z.Q. Liu, N.D. Ridgway, C.C. Kao, and J.J. He. Plos One, 2013. 8(9) : p. e75648; ISI[000324547300089] .

[WOS] OV_1011-102413.

33. Ester Prodrugs of Acyclic Nucleoside Thiophosphonates Compared to Phosphonates: Synthesis, Antiviral Activity and Decomposition Study. Roux, L., S. Priet, N. Payrot, C. Weck, M. Fournier, F. Zoulim, J. Balzarini, B. Canard, and K. Alvarez. European Journal of Medicinal Chemistry, 2013. 63: p. 869-881; ISI[000322855400085].

[WOS] OV_1011-102413.

34. Coumarins Hinged Directly on Benzimidazoles and Their Ribofuranosides to Inhibit Hepatitis C Virus. Tsay, S.C., J.R. Hwu, R. Singha, W.C. Huang, Y.H. Chang, M.H. Hsu, F.K. Shieh, C.C. Lin, K.C. Hwang, J.C. Horng, E. De Clercq, I. Vliegen, and J. Neyts. European Journal of Medicinal Chemistry, 2013. 63: p. 290-298; ISI[000322855400029].

[WOS] OV_1011-102413.